Reviva Pharmaceuticals Holdings Inc RVPH
$0.35 $0.44 (55.73%) 1D
Last Updated: May 13, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
RVPH Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Reviva Pharmaceuticals Holdings Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Reviva Pharmaceuticals Holdings Inc. Stock Analysis RVPH
United States Health Care Nano Cap Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. The company is headquartered in Cupertino, California and currently employs 14 full-time employees. The company went IPO on 2018-10-18. The firm discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, inflammatory, and cardiometabolic diseases. Its pipeline includes two drug candidates, brilaroxazine (RP5063) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).
Reviva Pharmaceuticals Holdings Inc (RVPH) Chart
Financial Metrics & Statements of Reviva Pharmaceuticals Holdings Inc (RVPH)
FAQ's for Reviva Pharmaceuticals Holdings Inc (RVPH)
- As of August 2026, Reviva Pharmaceuticals Holdings Inc RVPH is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Reviva Pharmaceuticals Holdings Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Reviva Pharmaceuticals Holdings Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Reviva Pharmaceuticals Holdings Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Reviva Pharmaceuticals Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Reviva Pharmaceuticals Holdings Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Reviva Pharmaceuticals Holdings Inc (RVPH)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
